1-3 of 3
Deborah Marcellus, MD
Close
Sort by
Journal Articles

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Patrick J. Stiff, MD, Hongli Li, PhD, James R. Cook, MD PhD, Louis S. Constine, MD, Stephen Couban, MD, Douglas A. Stewart, MD FRCPC, Thomas C. Shea, MD, Pierluigi Porcu, MD, Jane N. Winter, MD, Brad S Kahl, Sonali M. Smith, MD, Deborah Marcellus, MD, Kevin Barton, MD, Glenn M. Mills, MD, Michael LeBlanc, PhD, Lisa Rimsza, MD, Stephen J. Forman, MD, John P. Leonard, MD, Richard I. Fisher, MD, Jonathan Friedberg, MD
Journal: Blood
Blood (2016) 128 (22): 4651.
https://doi.org/10.1182/blood.V128.22.4651.4651
Published: 2016
Journal Articles

Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non−Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant

Kylie Lepic, MD, FRCPC, Ann Benger, MD, FRCP(C), Ronan Foley, MD, FRCPC, Graeme Fraser, Deborah Marcellus, MD, Michelle Saunders-Roy, RN, Michael Trus, MD, PhD, FRCPC, Anita Adams, RN(EC), MN, NP, CPMHN(C), Kari Kolm, RN(EC), MN, NP, Jennifer Wiernikowski, MN, NP, CON(C), C. Tom Kouroukis, MD, MSc, FRCPC
Journal: Blood
Blood (2011) 118 (21): 2091.
https://doi.org/10.1182/blood.V118.21.2091.2091
Published: 2011
Journal Articles

A Phase II Study of ZD6474, a Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients with Relapsed Multiple Myeloma (MM).

Michael J. Kovacs, MD, FRCPC, Donna E. Reece, MD, FRCPC, Deborah Marcellus, MD, Ralph M. Meyer, MD, Sarah Matthews, MSc, Rui-Ping Dong, MD, PhD, Elizabeth Eisenhauer, MD, FRCPC
Journal: Blood
Blood (2004) 104 (11): 3464.
https://doi.org/10.1182/blood.V104.11.3464.3464
Published: 2004